Aspire Biopharma Holdings, Inc. (ASBP)
NASDAQ: ASBP · Real-Time Price · USD
7.85
+0.74 (10.41%)
At close: Aug 14, 2026, 4:00 PM EDT
7.58
-0.27 (-3.44%)
After-hours: Aug 14, 2026, 7:48 PM EDT
Aspire Biopharma Holdings Market Cap
Aspire Biopharma Holdings has a market cap or net worth of $10.17 million as of August 14, 2026. Its market cap has decreased by -48.55% in one year.
Market Cap
10.17M
Enterprise Value
-2.00M
1-Year Change
-48.55%
Ranking
Category
Stock Price
$7.85
ChartMarket Cap Chart
Since April 11, 2022, Aspire Biopharma Holdings's market cap has decreased from $349.64M to $10.17M, a decrease of -97.09%. That is a compound annual growth rate of -55.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 10.17M | -28.28% |
| Dec 31, 2025 | 14.18M | -84.12% |
| Dec 18, 2024 | 89.29M | -8.80% |
| Dec 29, 2023 | 97.91M | -73.55% |
| Dec 30, 2022 | 370.15M | 5.86% |
| Apr 11, 2022 | 349.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| IN8bio | 10.84M |
| Intensity Therapeutics | 10.70M |
| GT Biopharma | 10.67M |
| CalciMedica | 10.67M |
| Instinct Bio Technical Company Holdings | 10.57M |
| BioVie | 10.56M |
| Theriva Biologics | 10.46M |
| Quoin Pharmaceuticals | 10.22M |